Hims & Hers is transforming from a controversial compounded-medication disruptor into a compliant, global, subscription-based consumer health platform with asymmetric upside if branded GLP-1s, international expansion, and AI-enabled care scale successfully.
Overview
Hims & Hers is a fast-growing digital health platform built around recurring, cash-pay telehealth subscriptions for stigmatized and chronic conditions. It serves digitally native consumers with convenient clinical access, personalized treatments, transparent pricing, and home delivery. The U.S. remains dominant, but international expansion accelerated through acquisitions including Eucalyptus, ZAVA, and Livewell. The company is evolving from a domestic consumer telehealth brand into a broader global consumer health platform spanning men’s health, women’s health, dermatology, mental health, diagnostics, and weight management.